Altium Capital Management LP Axsome Therapeutics, Inc. Put Options Transaction History
Altium Capital Management LP
- $0
- Q2 2025
Put Options
1 transactions
Others Institutions Holding AXSM
# of Institutions
401Shares Held
36.6MCall Options Held
755KPut Options Held
576K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$308 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million8.66% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$104 Million0.01% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...